Clinical Trial Update: Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating therapeutic monitoring of mycophenolate mofetil in kidney transplant recipients; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED